Similar Papers

Paper Title
Journal
Date
Author
Updated use of first-line chemotherapy for advanced pancreatic cancer: FOLFIRINOX versus gemcitabine.
Thomas H Cartwright ... Lalan S Wilfong
Journal of Clinical Oncology | VOL. 31
Thomas H Cartwright, et. al.Thomas H Cartwright ... Lalan S Wilfong
20 May 2013
Use of first-line chemotherapy for advanced pancreatic cancer: FOLFIRINOX versus gemcitabine.
Aimee Ginsburg Arlen ... Lalan S Wilfong
Journal of Clinical Oncology | VOL. 30
Aimee Ginsburg Arlen, et. al.Aimee Ginsburg Arlen ... Lalan S Wilfong
20 May 2012
An Overview of Clinical Trials of Targeted Therapies in Pancreatic Cancer
Bassel El-Rayes
-
Bassel El-RayesBassel El-Rayes
01 Jan 2008
Chemotherapy for advanced pancreatic cancer
...
Journal of International Oncology | VOL. 35
, et. al. ...
08 Apr 2008
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Rethinking the Path to Bladder Cancer Staging: Can Magnetic Resonance Imaging Speed Up Time to Receipt of Therapy in Patients With Muscle-Invasive Bladder Cancer?
Ashish M Kamat ... Paul Frankel
Journal of Clinical Oncology | VOL. -
Ashish M Kamat, et. al.Ashish M Kamat ... Paul Frankel
05 Feb 2025
Making Progress Along the Challenging Road of Drug Development for Patients With EGFR Exon 20 Insertion–Positive Non–Small Cell Lung Cancer
Zofia Piotrowska
Journal of Clinical Oncology | VOL. -
Zofia PiotrowskaZofia Piotrowska
05 Feb 2025
Combined Analyses of Circulating Tumor DNA and Immunoscore in Patients With Stage III Colon Cancer: A Post Hoc Analysis of the PRODIGE-GERCOR IDEA-France/HORG-IDEA-Greece Trials
Julien Taieb ... Pierre Laurent-Puig
Journal of Clinical Oncology | VOL. -
Julien Taieb, et. al.Julien Taieb ... Pierre Laurent-Puig
04 Feb 2025
Aiming Targeted Drug Development at Rare Pediatric Malignancies
Julia L Glade Bender
Journal of Clinical Oncology | VOL. -
Julia L Glade BenderJulia L Glade Bender
03 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.